FDA
Entity.
- Evidence
- 2,960 documents · 248 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 31 Oct 2026
- Measured
- 35% of mentions say something specific about it; the rest only name it
- As of
- 1 Nov 2026
Where this comes from
- STAT · 2026-10-30 · STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings (opens the source in a new tab)
- Citybiz · 2026-10-30 · NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Generic Ketamine Injection (opens the source in a new tab)
- an unnamed outlet · 2026-10-30 · INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) |… (opens the source in a new tab)
- Medical Device Network · 2026-10-30 · FDA expands approval of Instylla’s Embrace HES for arterial bleeds (opens the source in a new tab)
- FDA · 2026-10-30 · FDA Rationale for Breakpoints Recognition Decision: Minocycline for Stenotrophomonas maltophilia (opens the source in a new tab)
- Psychedelic Alpha · 2026-10-30 · FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending (opens the source in a new tab)
What is claimed about it
- Corroborated: Reported by three or more sources that did not copy each other.
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis Reported by two · first reported 30 Oct 2026
- STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings Single source · first reported 30 Oct 2026
- Abbott’s paravalvular leak treatment secures FDA approval Single source · first reported 30 Oct 2026
- CereVasc Receives FDA IDE Approval to Evaluate the eShunt® System in Patients with Alzheimer's Disease Could not check · first reported 29 Oct 2026
- FDA Advisory No.2026-1681 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “FIRST LINE FINGERTIP PULSE OXIMETER (YK-84C)” Single source · first reported 28 Oct 2026
- FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System Single source · first reported 28 Oct 2026
- FDA Warning: Two Lots of Darwin’s Natural Pet Products Cat Food Test Positive for Salmonella Could not check · first reported 27 Oct 2026
- STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies Single source · first reported 27 Oct 2026
- FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations Corroborated · first reported 26 Oct 2026
- fda approved over-the-counter weight loss drugs 2026 Could not check · first reported 26 Oct 2026
Situations it is named in
- Regulatory approval: FDAa situation that names it